Acalabrutinib plus Obinutuzumab in Treatment-Naïve and Relapsed/Refractory Chronic Lymphocytic Leukemia
Woyach, Jennifer A, Blachly, James S, Rogers, Kerry A, Bhat, Seema A, Jianfar, Mojgan, Lozanski, Gerard, Weiss, David M, Andersen, Barbara L, Gulrajani, Michael, Frigault, Melanie M, Hamdy, Ahmed, Izumi, Raquel, Munugalavadla, Veerendra, Quah, Cheng, Wang, Min-Hui, Byrd, John C
Published in Cancer discovery (01.03.2020)
Published in Cancer discovery (01.03.2020)
Get full text
Journal Article
Acalabrutinib in Combination with Venetoclax and Obinutuzumab or Rituximab in Patients with Treatment-Naïve or Relapsed/Refractory Chronic Lymphocytic Leukemia
Woyach, Jennifer A., Blachly, James S., Rogers, Kerry A., Bhat, Seema A, Grever, Michael R., Kittai, Adam S., Jianfar, Mojgan, Lozanski, Gerard, Weiss, David M., Andersen, Barbara L., Patel, Priti, Munugalavadla, Veerendra, Butturini, Anna, Xu, Yan, Wang, Min Hui, Byrd, John C.
Published in Blood (05.11.2020)
Published in Blood (05.11.2020)
Get full text
Journal Article
Acalabrutinib with obinutuzumab (Ob) in treatment-naive (TN) and relapsed/refractory (R/R) chronic lymphocytic leukemia (CLL): Three-year follow-up
Woyach, Jennifer Ann, Rogers, Kerry Anne, Bhat, Seema Ali, Blachly, James Stewart, Jianfar, Mojgan, Frigault, Melanie M., Hamdy, Ahmed M., Izumi, Raquel, Munugalavadla, Veerendra, Quah, Cheng Seok, Wang, Min Hui, Byrd, John C.
Published in Journal of clinical oncology (20.05.2019)
Published in Journal of clinical oncology (20.05.2019)
Get full text
Journal Article
Acalabrutinib with Obinutuzumab in Relapsed/Refractory and Treatment-Naive Patients with Chronic Lymphocytic Leukemia: The Phase 1b/2 ACE-CL-003 Study
Woyach, Jennifer A., Awan, Farrukh T., Jianfar, Mojgan, Rogers, Kerry A., Jones, Jeffrey, Covey, Todd, Hamdy, Ahmed, Izumi, Raquel, Patel, Priti, Wang, Min Hui, Byrd, John C.
Published in Blood (08.12.2017)
Published in Blood (08.12.2017)
Get full text
Journal Article
Acalabrutinib with Obinutuzumab in Treatment-Naive (TN) and Relapsed/Refractory (R/R) Patients with Chronic Lymphocytic Leukemia (CLL): 3-Year Follow-Up
Woyach, Jennifer A., Rogers, Kerry A., Bhat, Seema, Blachly, James, Jianfar, Mojgan, Frigault, Melanie M., Hamdy, Ahmed, Izumi, Raquel, Munugalavadla, Veerendra, Quah, Cheng, Wang, Min Hui, Byrd, John C.
Published in Clinical lymphoma, myeloma and leukemia (01.09.2019)
Published in Clinical lymphoma, myeloma and leukemia (01.09.2019)
Get full text
Journal Article